Cargando…

Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time‐resolved flow cytometry

Autofluorescence from the intracellular metabolite, NAD(P)H, is a biomarker that is widely used and known to reliably screen and report metabolic activity as well as metabolic fluctuations within cells. As a ubiquitous endogenous fluorophore, NAD(P)H has a unique rate of fluorescence decay that is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alturkistany, Faisal, Nichani, Kapil, Houston, Kevin D., Houston, Jessica P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587805/
https://www.ncbi.nlm.nih.gov/pubmed/30369063
http://dx.doi.org/10.1002/cyto.a.23606
_version_ 1783429143597154304
author Alturkistany, Faisal
Nichani, Kapil
Houston, Kevin D.
Houston, Jessica P.
author_facet Alturkistany, Faisal
Nichani, Kapil
Houston, Kevin D.
Houston, Jessica P.
author_sort Alturkistany, Faisal
collection PubMed
description Autofluorescence from the intracellular metabolite, NAD(P)H, is a biomarker that is widely used and known to reliably screen and report metabolic activity as well as metabolic fluctuations within cells. As a ubiquitous endogenous fluorophore, NAD(P)H has a unique rate of fluorescence decay that is altered when bound to coenzymes. In this work we measure the shift in the fluorescence decay, or average fluorescence lifetime (1–3 ns), of NAD(P)H and correlate this shift to changes in metabolism that cells undergo during apoptosis. Our measurements are made with a flow cytometer designed specifically for fluorescence lifetime acquisition within the ultraviolet to violet spectrum. Our methods involved culture, treatment, and preparation of cells for cytometry and microscopy measurements. The evaluation we performed included observations and quantification of the changes in endogenous emission owing to the induction of apoptosis as well as changes in the decay kinetics of the emission measured by flow cytometry. Shifts in NAD(P)H fluorescence lifetime were observed as early as 15 min post‐treatment with an apoptosis inducing agent. Results also include a phasor analysis to evaluate free to bound ratios of NAD(P)H at different time points. We defined the free to bound ratios as the ratio of ‘short‐to‐long’ (S/L) fluorescence lifetime, where S/L was found to consistently decrease with an increase in apoptosis. With a quantitative framework such as phasor analysis, the short and long lifetime components of NAD(P)H can be used to map the cycling of free and bound NAD(P)H during the early‐to‐late stages of apoptosis. The combination of lifetime screening and phasor analyses provides the first step in high throughput metabolic profiling of single cells and can be leveraged for screening and sorting for a range of applications in biomedicine. © 2018 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry.
format Online
Article
Text
id pubmed-6587805
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-65878052019-07-02 Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time‐resolved flow cytometry Alturkistany, Faisal Nichani, Kapil Houston, Kevin D. Houston, Jessica P. Cytometry A Original Articles Autofluorescence from the intracellular metabolite, NAD(P)H, is a biomarker that is widely used and known to reliably screen and report metabolic activity as well as metabolic fluctuations within cells. As a ubiquitous endogenous fluorophore, NAD(P)H has a unique rate of fluorescence decay that is altered when bound to coenzymes. In this work we measure the shift in the fluorescence decay, or average fluorescence lifetime (1–3 ns), of NAD(P)H and correlate this shift to changes in metabolism that cells undergo during apoptosis. Our measurements are made with a flow cytometer designed specifically for fluorescence lifetime acquisition within the ultraviolet to violet spectrum. Our methods involved culture, treatment, and preparation of cells for cytometry and microscopy measurements. The evaluation we performed included observations and quantification of the changes in endogenous emission owing to the induction of apoptosis as well as changes in the decay kinetics of the emission measured by flow cytometry. Shifts in NAD(P)H fluorescence lifetime were observed as early as 15 min post‐treatment with an apoptosis inducing agent. Results also include a phasor analysis to evaluate free to bound ratios of NAD(P)H at different time points. We defined the free to bound ratios as the ratio of ‘short‐to‐long’ (S/L) fluorescence lifetime, where S/L was found to consistently decrease with an increase in apoptosis. With a quantitative framework such as phasor analysis, the short and long lifetime components of NAD(P)H can be used to map the cycling of free and bound NAD(P)H during the early‐to‐late stages of apoptosis. The combination of lifetime screening and phasor analyses provides the first step in high throughput metabolic profiling of single cells and can be leveraged for screening and sorting for a range of applications in biomedicine. © 2018 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry. John Wiley & Sons, Inc. 2018-10-19 2019-01 /pmc/articles/PMC6587805/ /pubmed/30369063 http://dx.doi.org/10.1002/cyto.a.23606 Text en © 2018 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Alturkistany, Faisal
Nichani, Kapil
Houston, Kevin D.
Houston, Jessica P.
Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time‐resolved flow cytometry
title Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time‐resolved flow cytometry
title_full Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time‐resolved flow cytometry
title_fullStr Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time‐resolved flow cytometry
title_full_unstemmed Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time‐resolved flow cytometry
title_short Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time‐resolved flow cytometry
title_sort fluorescence lifetime shifts of nad(p)h during apoptosis measured by time‐resolved flow cytometry
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587805/
https://www.ncbi.nlm.nih.gov/pubmed/30369063
http://dx.doi.org/10.1002/cyto.a.23606
work_keys_str_mv AT alturkistanyfaisal fluorescencelifetimeshiftsofnadphduringapoptosismeasuredbytimeresolvedflowcytometry
AT nichanikapil fluorescencelifetimeshiftsofnadphduringapoptosismeasuredbytimeresolvedflowcytometry
AT houstonkevind fluorescencelifetimeshiftsofnadphduringapoptosismeasuredbytimeresolvedflowcytometry
AT houstonjessicap fluorescencelifetimeshiftsofnadphduringapoptosismeasuredbytimeresolvedflowcytometry